The American Society for Radiation Oncology (ASTRO) selected 43 members to receive the ASTRO Fellow (FASTRO) designation this year. This prestigious honor recognizes ASTRO members’ outstanding achievements and contributions to the Society, cancer research, education, patient care and the specialty. The new Fellows will be recognized at ASTRO’s 67th Annual Meeting in San Francisco on Tuesday, September 30.

The 2025 ASTRO Fellows include physicians, physicists and cancer biologists whose work advances radiation therapy’s critical role in cancer treatment. The FASTRO designation has been awarded to just 541 of ASTRO’s 10,000 members worldwide since its inception in 2006.

“These distinguished leaders embody ASTRO’s core principles of excellence, innovation and unwavering dedication to improving patients’ lives through radiation oncology. On behalf of ASTRO, we celebrate their elevation to FASTRO status and their meaningful contributions to cancer care,” said Howard M. Sandler, MD, FASTRO, Chair of the ASTRO Board of Directors.

The 2025 Fellows are:

• Jonathan Ashman, MD, PhD, Mayo Clinic College of Medicine and Science, Phoenix
• Stanley Benedict, PhD, Virginia Commonwealth University, MCV Massey Cancer Center
• Higinia Rosa Cardenes Perera, MD, PhD, New York Presbyterian, Weill Cornell Medical Center
• Annie W. Chan, MD, Massachusetts General Hospital
• Zhe (Jay) Chen, PhD, Yale University
• Jennifer F. De Los Santos, MD, Washington University School of Medicine in St. Louis
• Hans Theodor Eich, MD, PhD, University of Muenster
• Moataz El-Ghamry, MD, Baylor Scott & White Health
• Clifton (Dave) Fuller, MD, PhD, The University of Texas MD Anderson Cancer Center
• Daniel R. Gomez, MD, MBA, Memorial Sloan Kettering Cancer Center
• Chandan Guha, MD, PhD, MBBS, Montefiore Medical Center, Albert Einstein College of Medicine
• Ying J. Hitchcock, MD, University of Utah Huntsman Cancer Institute
• Kathleen Horst, MD, Stanford University
• Geoffrey Hugo, PhD, Washington University School of Medicine in St. Louis
• Christopher Jahraus, MD, Generations Radiotherapy and Oncology PC
• Rachel Jimenez, MD, Massachusetts General Hospital
• Melissa Joyner, MD, MBA, The University of Texas MD Anderson Cancer Center
• Brent Kane, MD, Community Physicians Group
• Elizabeth Kidd, MD, Stanford University
• Daniel Krauss, MD, Corewell Health William Beaumont University Hospital
• Nicole A. Larrier, MD, MS, Duke University Medical Center
• Steven H. Lin, MD, PhD, The University of Texas MD Anderson Cancer Center
• Janice Lyons, MD, University Hospitals, Seidman Cancer Center
• Chika N. Madu, MD, Northwell Health
• Heyoung Lee McBride, MD, MS, Tampa General Medical Group, University of South Florida
• Joshua Meyer, MD, Fox Chase Cancer Center
• Drew Moghanaki, MD, MPH, UCLA David Geffen School of Medicine
• Sabin Motwani, MD, Jersey City Medical Center Radiation Oncology
• Subhakar Mutyala, MD, MBA, MPH, FABS, Arizona Center for Cancer Care
• Kenneth Olivier, MD, Mayo Clinic College of Medicine and Science Rochester
• Harold Paganetti, PhD, Massachusetts General Hospital
• Rahul Parikh, MD, MBA, Rutgers Cancer Institute of New Jersey
• John Plastaras, MD, PhD, University of Pennsylvania
• Andreas Rimner, MD, University of Freiburg
• Mihaela Rosu-Bubulac, PhD, Virginia Commonwealth University
• Narayan Sahoo, PhD, The University of Texas MD Anderson Cancer Center
• Parag Sanghvi, MD, MSPH, University of California, San Diego
• Naomi Schechter, MD, South Florida Proton Therapy Institute
• Farzan Siddiqui, MD, PhD, Henry Ford Health/Henry Ford Hospital
• Gita Suneja, MD, MS, Huntsman Cancer Institute at the University of Utah
• Andrew Wang, MD, University of Texas Southwestern Medical Center
• Jennifer Wo, MD, Massachusetts General Hospital
• Rebecca Wong, MBChB, MS, Princess Margaret Cancer Centre

Candidates for Fellow designation are nominated by current ASTRO Fellows, undergo rigorous peer review and are approved by ASTRO’s Board of Directors. More information about the Fellows program is available on the ASTRO website, including the complete list of ASTRO Fellows.

ABOUT ASTRO
The American Society for Radiation Oncology (ASTRO) is the world’s largest professional society dedicated to advancing radiation oncology, with approximately 10,000 members including physicians, nurses, physicists, radiation therapists, dosimetrists and other professionals who work to improve patient outcomes through clinical care, research, education and policy advocacy. Radiation therapy is integral to 40% of cancer cures worldwide, and more than one million Americans receive radiation treatments for their cancer each year. For information on radiation therapy, visit RTAnswers.org. To learn more about ASTRO, visit our website and media center and connect with us on social media.